최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한한방내과학회지 = The journal of internal Korean medicine, v.41 no.4, 2020년, pp.668 - 675
정현진 (동신대학교 광주한방병원 한방내과) , 전상윤 (동신대학교 목포한방병원 한방내과) , 장혜연 (동신대학교 광주한방병원 한방내과) , 김민욱 (동신대학교 광주한방병원 한방침구의학과)
Objectives: The aim of this study was to compare the effects of Galkunhwanglyeonhwanggum-tang (GGT), and Sopunghwalhyeol-tang (SPT) on gene expression of MCP-1, ICAM-1, VCAM-1, and eNOS in human umbilical vein endothelial cells (HUVECs). Methods: HUVECs were treated with GGT and SPT at concentration...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
죽상동맥경화증은 어떤 질환인가? | 죽상동맥경화증(atherosclerosis)은 동맥 내에 죽상판 또는 섬유지방판을 형성하는 질환으로 혈관의 내강을 좁히고, 중막을 약화시켜 심근경색, 뇌경색 및 대동맥 동맥류 등의 합병증을 초래한다1. | |
어떤 단핵구가 혈관 내피세포에 부착되어 죽상동맥경화증의 진행에 영향을 미치는가? | 단핵구는 세포부착분자인 ICAM-1(Intercellular cell adhesionmolecule-1), VCAM-1(Vascular celladestion molecule-1)을 통해 혈관 내피세포에 부착하여 죽상동맥경화증의 진행에 영향을 미친다4. | |
혈관 내피 염증이란 어떤 과정인가? | 이는 혈관 내피 염증 발생과 연관되며, 죽상동맥경화증의 발생 기전에 혈관내피의 염증 발생 단계는 중요하다. 혈관 내피의 염증은 산화적인 손상에 의해 유발되고, 염증 진행과정에서 단핵구가 혈관의 내피에 부착하는 과정이다3. |
Kang DY, Patholgy. Seoul: Komunsa; 2004, p. 349-53.
Wong ND, Cuples LA, Ostfeld AM, Levy D, Danel WB. Risk factors for long-term coronary prognosis after inital myocardial infarction. The Framingham Study. Am J Epidemiol 1989;130(3):469-80.
Rong Y, Geng Z, Lau BH. Ginko biloba attenuates oxidative stress in macrophages and endothelial cells. Free Radic Biol Med 1996;20(1):121-7.
Stein O, Thiery J, Stein Y. Is there a genetic basis for resistance to atherosclerosis? Atherosclerosis 2002;160(1):1-10.
Wen MC, Wei CH, Hu ZQ, Srivastava K, Ko J, Xi ST, et al. Efficacy and tolerability ofanti-asthma herbalmedicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol 2005;116(3):517-24.
Mc Kenney JM. Lipid management: tools for gettingto the goal. Am J Manag Care 2001;7(9 Suppl):S299-306.
Miettinen TA. Cholesterol absorption inhibition: astrategy for cholesterol-lowering therapy. Int J Clin Pract 2001;55(10):710-6.
Jeong WY, An KS. 韓方臨床病理學. Seoul: Yunglimsa: 1998, p. 545.
Bang HJ, Kang YH. 고지혈증의 처방에 관한 문헌적 고찰. 동서의학. 1996;21(2):70-81.
Kim WS, Lee YS, Cha SH, Jeong HW, Choe SS, Lee MR, et al. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. American Journal of Physiological Endocrinology Metabolism 2009;296(4):812-9.
Stenvinkel P. Interactions between inflammation, oxidative stress and endothelial dysfunction in end-stage renal disease. J Renal Nutrition 2003;13(2):144-8.
The Relationship between Coronary Risk Factors and Coronary Calcium Score Detected by Computed Tomography Coronary Angiography in Korean Middle Aged Men. Journal of agricultural medicine & community health 2014;39(1):25-36.
Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992;326(4):242-50.
The Warfarin-Aspirin Symptomatic Intracranial Disease(WASID) Trial Investigatiors. Design, progress and challenges of double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neutroepidemiology 2003;22(2):106-17.
국가통계포털 KOSIS(htp:/kosis.kr) $\bigcirc$ DB : 보건.사회.복지 > 보건 > 사망원인통계
Yun HJ, Heo SK, Le YT, Park WH, Park SD. Antiinflammatory effect of Evodia officinalis DODE in mouse macrophage and human vascular endothelial cells. Kor J Herbology 2008;23(1):29-38.
Liby P. Inflammation in atherosclerosis. Nature 2002;420(6917):868-74.
Ito T, Ikeda U. Inflammatory cytokines and cardiovascular disease. Cur Drug Targets Inflamm Allergy 2003;2(3):257-65.
Cheon MS, Yon T, Choi G, Kim SJ, Le AY, Mon BC, et al. Comparative study of extracts from rhubarb on inflammatory activity in RAW 264.7 cels. Korean J Medicinal Crop Sci 2009:17(2):109-14.
Li J, Zhu CG, Yu B, Liu YX, Yu MY. The role of inflammation in coronary artery calcification. Ageing Res Rev 2007;6(4):263-70.
Lee JH. Ilustration of the TCM Diagnosis. Wonju: Publications EuiBang; 2004, p. 79.
沈金資. 沈氏尊生書. 臺北: 自由出版社; 1980, p. 309-17.
Heo J. Dongeuibogam. Seoul: Namsandang; 1989, p. 86, 90, 106.
黃度淵. 證脈方藥合編. Seoul: Namsandang; 1992, p. 125, 126.
Gedeit RG. Tumor necrosis factor-induced E-selectin expression on vascular endothelial cells. Cxit Care Med 1996;24(9):1543-6.
Imhof BA, Dunun D. Basic mechanism of leukocyte migration. Horm Metab Res 1997;29(12):614-21.
Baran D, Vendeville B, Ogborn M, Katz N, Rubin E, Nguyen V. Cell adhesion molecule expression in murine lupus-like nephritis induced by lipopolysaccharide. Nephron 2000;84:167-76.
Power CA, Proudfoot AE. The chemokine system: novel broad-spectrum therapeutic targets. Curr Opin Pharmacol 2001;1(4):417-24.
Gosling J,Slaymaker S, Gu L,Tseng S,Zlot CH, Young SG, et al. MCP-1 deficiency reduces susceptibility to atheroslcerosis in mice that overexpress human apolipoprotein B. J Clin Invest 1999;103(6):773-8.
Baggiolini M, Loetscher P. Chemokines in inflammation and immunity. Immunol Today 2000;21(9):418-20.
Takeya M, Yoshimura T, Leonard EJ. Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 1993;24(5):534-9.
Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88(4):1121-7.
Seino Y, Ikeda U,Sekiguchi H, Morita M. Konishi K, Kasahara T, et al. Expression of monocyte chemoattactant protien-1 in vascularb tissue. Cytokine 1995;7(6):575-9.
Harrington JR. The role of MCP-1 in atherosclerosis. Stem Cells 2000;18(1):65-6.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.